Encompass Health Corporation

64.33-0.2600-0.40%Vol 426.28K1Y Perf 13.90%
Nov 29th, 2023 16:00 DELAYED
BID63.10 ASK80.05
Open64.90 Previous Close64.59
Pre-Market- After-Market64.76
 - -  0.43 0.67%
Target Price
64.89 
Analyst Rating
Strong Buy 1.30
Potential %
0.87 
Finscreener Ranking
★+     44.44
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     39.74
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     49.58
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
     33.14
Price Range Ratio 52W %
63.02 
Earnings Rating
Neutral
Market Cap6.45B 
Earnings Date
26th Oct 2023
Alpha-0.00 Standard Deviation0.09
Beta1.02 

Today's Price Range

64.2765.21

52W Range

51.1572.06

5 Year PE Ratio Range

10.6025.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-2.23%
1 Month
6.15%
3 Months
-8.99%
6 Months
7.81%
1 Year
13.90%
3 Years
-21.09%
5 Years
-12.88%
10 Years
100.51%

TickerPriceChg.Chg.%
EHC64.33-0.2600-0.40
AAPL189.37-1.0300-0.54
GOOG136.40-2.2200-1.60
MSFT378.85-3.8500-1.01
XOM102.34-1.5600-1.50
WFC43.780.41000.95
JNJ152.110.48000.32
FB196.640.99000.51
GE118.860.01000.01
JPM154.320.78000.51
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.20
0.70
2.42
4.20
Leverage Ratio 3.80
ProfitabilityValueIndustryS&P 500US Markets
95.90
13.90
19.00
12.00
7.74
RevenueValueIndustryS&P 500US Markets
3.21B
32.18
4.98
6.28
DividendsValueIndustryS&P 500US Markets
0.99
0.60
11.18
11.65
Payout ratio29.00
Earnings HistoryEstimateReportedSurprise %
Q03 20230.770.8611.69
Q02 20230.740.9528.38
Q01 20230.700.8825.71
Q04 20220.850.883.53
Q03 20220.680.67-1.47
Q02 20220.970.89-8.25
Q01 20220.930.974.30
Q04 20211.060.97-8.49
Earnings Per EndEstimateRevision %Trend
12/2023 QR0.83-2.35Negative
12/2023 FY3.522.03Positive
3/2024 QR0.91-1.09Negative
12/2024 FY3.834.08Positive
Next Report Date-
Estimated EPS Next Report0.77
Estimates Count7
EPS Growth Next 5 Years %13.50
Volume Overview
Volume426.28K
Shares Outstanding100.24K
Shares Float98.34M
Trades Count8.81K
Dollar Volume27.50M
Avg. Volume495.81K
Avg. Weekly Volume318.11K
Avg. Monthly Volume576.48K
Avg. Quarterly Volume592.85K

Encompass Health Corporation (NYSE: EHC) stock closed at 64.59 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 324.15K shares and market capitalization of 6.45B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 43178 people. Encompass Health Corporation CEO is Mark J. Tarr.

The one-year performance of Encompass Health Corporation stock is 13.9%, while year-to-date (YTD) performance is 7.99%. EHC stock has a five-year performance of -12.88%. Its 52-week range is between 51.15 and 72.0631, which gives EHC stock a 52-week price range ratio of 63.02%

Encompass Health Corporation currently has a PE ratio of 22.60, a price-to-book (PB) ratio of 5.04, a price-to-sale (PS) ratio of 1.88, a price to cashflow ratio of 9.40, a PEG ratio of 1.67, a ROA of 4.86%, a ROC of 8.65% and a ROE of 19.54%. The company’s profit margin is 7.74%, its EBITDA margin is 19.00%, and its revenue ttm is $3.21 Billion , which makes it $32.18 revenue per share.

Of the last four earnings reports from Encompass Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.77 for the next earnings report. Encompass Health Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Encompass Health Corporation is Strong Buy (1.3), with a target price of $64.89, which is +0.87% compared to the current price. The earnings rating for Encompass Health Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Encompass Health Corporation has a dividend yield of 0.99% with a dividend per share of $0.60 and a payout ratio of 29.00%.

Encompass Health Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 5.72, ATR14 : 1.17, CCI20 : 54.17, Chaikin Money Flow : 0.04, MACD : 0.27, Money Flow Index : 50.30, ROC : 0.84, RSI : 50.93, STOCH (14,3) : 53.53, STOCH RSI : 0.00, UO : 53.15, Williams %R : -46.47), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Encompass Health Corporation in the last 12-months were: Coltharp Douglas (Option Excercise at a value of $800 493), Coltharp Douglas (Sold 29 110 shares of value $1 798 577 ), Douglas E. Coltharp (Option Excercise at a value of $359 153), Douglas E. Coltharp (Sold 17 895 shares of value $1 087 658 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (80.00 %)
8 (80.00 %)
8 (80.00 %)
Moderate Buy
1 (10.00 %)
1 (10.00 %)
1 (10.00 %)
Hold
1 (10.00 %)
1 (10.00 %)
1 (10.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.30
Strong Buy
1.30
Strong Buy
1.30

Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. It operates in two segments: inpatient rehabilitation and home health and hospice. The Inpatient rehabilitation segment contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas. The Home health and hospital segment provides skilled home health services through agencies concentrated in the southeastern United States and Texas, which include nursing, physical, occupational, and speech therapy, social work, and hospice services.

CEO: Mark J. Tarr

Telephone: +1 205 967-7116

Address: 9001 Liberty Parkway, Birmingham 35242, AL, US

Number of employees: 43 178

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

57%43%

Bearish Bullish

54%46%

 

TipRanks News for EHC

Mon, 27 Nov 2023 13:37 GMT Encompass Health names Spirit Airlines CEO Ted Christie to board

- TipRanks. All rights reserved.

Fri, 27 Oct 2023 09:50 GMT Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC) and Sanofi (OtherSNYNF)

- TipRanks. All rights reserved.

Fri, 29 Sep 2023 06:40 GMT Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Encompass Health (EHC) and Xencor (XNCR)

- TipRanks. All rights reserved.

Wed, 23 Aug 2023 20:55 GMT Enhabit begins exploration of strategic alternatives

- TipRanks. All rights reserved.

Wed, 02 Aug 2023 10:07 GMT Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), IQVIA Holdings (IQV)

- TipRanks. All rights reserved.

News

Stocktwits